Effect of Treatment for Chlamydia pneumoniae and Helicobacter pylori on Markers of Inflammation and Cardiac Events in Patients With Acute Coronary Syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA)

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Circulation

• Publication date

  2002-09-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000027820.66786.CFPMID 12208796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree?

  2002cited by this paper
• Effect of 3 Months of Antimicrobial Treatment With Clarithromycin in Acute Non–Q-Wave Coronary Syndrome

  2002cited by this paper
• Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis

  2002cited by this paper
• On evolutionary biology, inflammation, infection, and the causes of atherosclerosis.

  2002cited by this paper
• Problems and perspectives in the treatment of respiratory infections caused by atypical pathogens.

  2001cited by this paper
• Chlamydia pneumoniae Infection in Circulating Human Monocytes Is Refractory to Antibiotic Treatment

  2001cited by this paper
• Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

  2000cited by this paper
• Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease: Primary Clinical Results of the ACADEMIC Study

  2000cited by this paper
• Lansoprazole Decreases Peripheral Blood Monocytes and Intercellular Adhesion Molecule-1-Positive Mononuclear Cells

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.

  1999cited by this paper
• Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.

  1999cited by this paper
• Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease.

  1999cited by this paper
• Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.

  1999cited by this paper
• Effect of Azithromycin plus Rifampin versus That of Azithromycin Alone on the Eradication of Chlamydia pneumoniae from Lung Tissue in Experimental Pneumonitis

  1999cited by this paper
• The OAC and OMC options.

  1999cited by this paper
• Evaluation of PCR, Culture, and Serology for Diagnosis of Chlamydia pneumoniae Respiratory Infections

  1998cited by this paper
• Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

  1998cited by this paper
• Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.

  1998cited by this paper
• Short‐term low‐dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori

  1997cited by this paper
• Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.

  1997cited by this paper
• C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

  1996cited by this paper
• Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men.

  1996cited by this paper
• Non-antibiotic effect of antibiotic

  1996cited by this paper
• Effects of metronidazole and its metabolites on histamine immunosuppression activity.

  1996cited by this paper
• Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: a potential mechanism of its anti-inflammatory action.

  1995cited by this paper
• Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

  1995cited by this paper
• Haemostasis Factors in Angina Pectoris; Relation to Gender, Age and Acute-phase Reaction

  1995cited by this paper
• Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease.

  1995cited by this paper
• In vivo effect of omeprazole on HLA-DR expression and the monocyte-macrophage function in patients with duodenal ulcer disease.

  1994cited by this paper
• In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against chlamydia

  1994cited by this paper
• Pharmacokinetic aspects of antibacterial prophylaxis.

  1993cited by this paper
• Comparison of macrolide antibiotics.

  1993cited by this paper
• Unstable angina. A classification.

  1989cited by this paper
• Antibiotics and inflammatory bowel diseases.

  1989cited by this paper
• Unstable Angina A Classification

  1989cited by this paper
• In vitro drug susceptibility of Chlamydia sp. strain TWAR

  1988cited by this paper
• Modulation of lymphocyte adrenergic receptors and transformation responses by therapeutic drugs.

  1984cited by this paper
• Modulation of lymphocyte adrenergic receptors and transformation responses by therapeutic drugs.

  1984cited by this paper

• Gut Microbiota And Cardiovascular Disease

  2025cites this paper
• Viridans Streptococcal Biofilm Evades Immune Detection and Contributes to Inflammation and Rupture of Atherosclerotic Plaques

  2025cites this paper
• Beyond the gut: a comprehensive meta-analysis on Helicobacter pylori infection and cardiovascular complications

  2025cites this paper
• Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases

  2023cites this paper
• Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment

  2022cites this paper
• Helicobacter pylori-Related Extraintestinal Manifestations—Myth or Reality

  2022cites this paper
• The role of the gut microbiota in health and cardiovascular diseases

  2022cites this paper
• The evidence for a role of bacteria and viruses in cardiovascular disease

  2022cites this paper
• Bacterial Infections and Atherosclerosis – A Mini Review

  2022cites this paper
• Evaluation of Effect of Influenza-Like Virus in Adults: A Case Control Study on Adults with Myocardial Infarction Problems

  2022cites this paper
• Antibiotics for secondary prevention of coronary heart disease.

  2021cites this paper
• Periodontal therapy and cardiovascular risk.

  2020cites this paper
• Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events

  2020cites this paper
• Helicobacter pylori and Cardiovascular Diseases

  2020cites this paper
• Full title: Managing cardiovascular risk of macrolides: systematic review and meta- analysis Running title: Managing cardiovascular risk of macrolides

  2019cites this paper
• Host and Bacterial Markers that Differ in Children with Cystitis and Pyelonephritis.

  2019cites this paper
• Biomarkers that differentiate false positive urinalyses from true urinary tract infection

  2019cites this paper
• Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides

  2018cites this paper
• Tropical Coronary Artery Disease and Arrhythmogenic Potentials

  2018cites this paper
• Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction

  2018cites this paper
• Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?

  2017cites this paper
• Helicobacter pylori eradication to prevent cardio-cerebrovascular diseases: Are current data useful for clinical practice?

  2017cites this paper
• The effect of Helicobacter pylori eradication on arterial stiffness and qt dispersion

  2017cites this paper
• Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis

  2017cites this paper
• [Analysis of the clinical efficiency of eradication therapy in patients with coronary heart disease associated with gastroduodenal pathology].

  2017cites this paper
• Infections, atherosclerosis, and coronary heart disease.

  2017cites this paper
• Extraintestinal Manifestations of H. pylori Infection: Heart Disease

  2016cites this paper
• Helicobacter pylori infection and ischemic heart disease: could experimental data lead to clinical studies?

  2016cites this paper
• Reproducible Research Practices and Transparency across the Biomedical Literature

  2016cites this paper
• Non-anti-infective effects of antimicrobials and their clinical applications: a review.

  2015cites this paper
• Effects of Helicobacter pylori Infection and Its Eradication on Lipid Profiles and Cardiovascular Diseases

  2015cites this paper
• Perfil inflamatório de pacientes submetidos à endarterectomia de carótida e sua relação com doença periodontal crônica

  2015cites this paper
• Danger signaling in atherosclerosis.

  2015cites this paper
• Cardiovascular Diseases and Periodontal Diseases: Review and Update

  2015cites this paper
• Ateroesclerosis asociada a infección por chlamydophila pneumoniae: interacción entre el ser humano y una bacteria

  2015cites this paper
• Helicobacter Pylori and non-Malignant Haematological Disorders in Adults

  2014cites this paper
• Viewofstatinsasantimicrobials incardiovascularrisk modification

  2014cites this paper
• Helicobacter pylori Infection and Eye Diseases: A Systematic Review

  2014cites this paper
• The heart and the gut.

  2014cites this paper
• Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence

  2014cites this paper
• View of statins as antimicrobials in cardiovascular risk modification.

  2014cites this paper
• Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials.

  2014cites this paper
• [The course of coronary heart disease concurrent with peptic ulcer disease: clinical and pathogenetic aspects].

  2014cites this paper
• Das Risikofaktorenkonzept in der kardiologischen Rehabilitation: eine ethnographische Studie

  2014cites this paper
• Macrolide antibiotics and the risk of cardiac arrhythmias.

  2014cites this paper
• The heart and other organs The heart and the gut

  2014cites this paper
• Early prognosis of unstable angina patients with positive Helicobacter pylori IgG values

  2013cites this paper
• Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions.

  2013cites this paper
• Infections and atheromatous plaque: current therapeutic implications.

  2013cites this paper
• Immunity, atherosclerosis and cardiovascular disease

  2013cites this paper
• Azithromycin: more lethal than chloramphenicol?

  2013cites this paper
• Chlamydophila Pneumoniae Infection and Cardiovascular Disease

  2013cites this paper
• Chlamydia pneumoniae in the atherosclerotic plaques of coronary artery disease patients.

  2013cites this paper
• Immune Mechanisms in Atherosclerosis, Especially in Diabetes Type 2

  2013cites this paper
• Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial.

  2012cites this paper
• Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study

  2012cites this paper
• Mechanisms of Vascular Disease

  2012cites this paper
• C-reactive protein (CRP) is a predictor of high medical-care expenditures in a community-based elderly population aged 70 years and over: the Tsurugaya project.

  2012cites this paper
• Screening and High CV Risk Patients

  2012cites this paper
• Antibiotics in the prevention and management of coronary heart disease- A revisit

  2012cites this paper
• The Infectious Burden in Atherothrombosis

  2012cites this paper
• Intestinal microbiota determine severity of myocardial infarction in rats

  2012cites this paper
• Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association.

  2012cites this paper
• Independent Association? : A Scientific Statement From the American Heart Association Periodontal Disease and Atherosclerotic Vascular Disease: Does the Evidence Support an

  2012cites this paper
• Evaluation Of Periodontal Status And High Sensitive Serum C-Reactive Protein Levels In Subjects With Coronary Heart Disease

  2012cites this paper
• Atherosclerosis and infection: is the jury still not in?

  2012cites this paper
• Mechanisms of Plaque Rupture

  2011cites this paper
• Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis

  2011cites this paper
• Obtención de nuevos inmunógenos de Chlamydophila pneumoniae mediante inmunoscreening para su aplicación en el serodiagnóstico

  2011cites this paper
• Helicobacter Pylori Infection and Long Term Prognosis in Patients with Acute Coronary Syndrome

  2011cites this paper
• Helicobacter pylori infection and acute myocardial infarction.

  2011cites this paper
• Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study.

  2010cites this paper
• Chlamydia pneumoniae e doença aterosclerótica Chlamydia pneumoniae and atherosclerotic disease

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey

  2010cites this paper
• Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis

  2010cites this paper
• Infección por Helicobacter pylori y pronóstico a largo plazo en pacientes con síndrome coronario agudo

  2010cites this paper
• PONTIFÍCIA UNIVERSIDADE CATÓLICA DO RIO GRANDE DO SUL PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA E CIÊNCIAS DA SAÚDE ÁREA DE CONCENTRAÇÃO: CLÍNICA MÉDICA

  2010cites this paper
• Zusammenhang zwischen Helicobacter pylori und angiographisch nachgewiesener koronarer Herzkrankheit : Erregernachweis mittels verschiedener Testmethoden

  2010cites this paper
• LEUKOCYTURIA AND CORONARY ARTERY DISEASE: FURTHER EVIDENCE TO THE PRESENCE OF INFLAMMATORY PROCESSES IN ACUTE CORONARY SYNDROME

  2010cites this paper
• Valor pronóstico de la respuesta serológica debida a Helicobacter pylori en la evolución a largo plazo del síndrome coronario agudo

  2010cites this paper
• Prognostic value of the Serological Response to Helicobacter Pylori in the Long-Term Outcomes of Acute Coronary Syndrome

  2010cites this paper
• IL-6, TNF-alpha, IL-1-beta arterial wall expression is independent of serum concentration in patients sustaining primary or secondary open vascular reconstructions.

  2010cites this paper
• [Macrolides and ketolides].

  2009cites this paper
• Novel pathogenic insights in the primary prevention of cardiovascular disease.

  2009cites this paper
• Insights Into the Role of Infection in Atherogenesis and in Plaque Rupture

  2009cites this paper
• Azithromycin-containing versus standard triple therapy for Helicobacter pylori eradication: a meta-analysis.

  2009cites this paper
• Links Between Infectious Diseases and Cardiovascular Disease: A Growing Body of Evidence

  2009cites this paper
• Seasonal variation in acute myocardial infarction.

  2009cites this paper
• Kardiovaskuläre Risikofaktoren und deren therapeutische Beeinflussung

  2009cites this paper
• Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review.

  2009cites this paper
• Characterization of biofilm formed by human-derived nanoparticles.

  2009cites this paper
• Possible association of atrophic gastritis and arterial stiffness in healthy middle-aged Japanese.

  2009cites this paper
• Helicobacter pylori and atherosclerosis: can current data be useful for clinical practice?

  2008cites this paper
• Major histocompatibility complex and coronary artery disease: Special emphasis on Chlamydia pneumoniae, and periodontitis

  2008cites this paper
• [Does Helicobacter pylori infection play a role in extragastric diseases?].

  2008cites this paper
• Role of Chlamydia pneumoniae in atherosclerosis.

  2008cites this paper
• A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases.

  2008cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 340 Chlamydophila pneumoniae in Cardiovascular Diseases Clinical and Experimental Studies

  2008cites this paper
• Correlates of periodontal decline and biologic markers in older adults.

  2008cites this paper